Cytokinetics Inc
(MIL:1CYTK)
€
62.98
(0%)
Market Cap: 8.33 Bil
Enterprise Value: 8.42 Bil
PE Ratio: 0
PB Ratio: 0
GF Score: 30/100 Cytokinetics, Incorporated at Morgan Stanley Global Healthcare Conference Transcript
Sep 14, 2026 / 11:45AM GMT
Release Date Price:
€62.98
Maxwell Skor
Morgan Stanley - Moderator
Great. Thank you everyone for joining. I am Max Skor, a biotech analyst with Morgan Stanley. Before we get started, for important disclosures, please see the Morgan Stanley Research Disclosure website at www.morganstanley.com/researchdisclosures. I am very happy to welcome the Cytokinetics team, Robert Blum, CEO; Sung Lee; CFO, Andrew Callos, Chief Commercial Officer; Fady Malik, Research and Development. Welcome [Bert], welcome, team. Thank you very much for joining us today.
Robert Blum
Cytokinetics, Incorporated - President, Chief Executive Officer, Director
Thank you.
Questions & Answers
Maxwell Skor;Robert Blum
Morgan Stanley - Moderator;
Maybe just to start off, Robert, we are in the early stages of the MYQORZO launch. Could you just walk us through key learnings at this point and what we should really focus on going forward into year-end?
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot